Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases

Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group

Lee S. Rosen, David Gordon, Simon Tchekmedyian et al. · Journal of Clinical Oncology · 2003 · 727 citations

Medicine, Oncology, Pharmacotherapy +17

Long‐term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors

Lee S. Rosen, David Gordon, N. Simon Tchekmedyian et al. · Cancer · 2004 · 716 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Zoledronic Acid Significantly Reduces Skeletal Complications Compared With Placebo in Japanese Women With Bone Metastases From Breast Cancer: A Randomized, Placebo-Controlled Trial

Norio Kohno, Kenjiro Aogi, Hironobu Minami et al. · Journal of Clinical Oncology · 2005 · 545 citations

Medicine, Oncology, Pharmacotherapy +17

ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis

Xin Lü, Qiongqing Wang, Guohong Hu et al. · Genes & Development · 2009 · 303 citations · Full text

Medicine, Molecular Biology, Oncology +17

Skeletal metastases in non-small cell lung cancer: A retrospective study

Asuka Tsuya, Takayasu Kurata, Kenji Tamura et al. · Lung Cancer · 2007 · 289 citations

Medicine, Oncology, Surgery +16